US cannabis operator Ayr Wellness saw good numbers last year helped by cost-saving measures, stepping back from markets that did not align with its business goals, and investing in other different markets.
“By better prioritising our time, our attention, and our capital, we find ourselves better positioned to capture growth opportunities in our existing and future footprint, which we anticipate will help us grow our cash flow profile, our revenue, and adjusted EBITDA margins consistently throughout 2023,” Ayr’s president and CEO David Goubert said when presenting the company’s 2022 results.